Home › Funds › CVS HEALTH Corp › VCIT
CVS HEALTH Corp position in VCIT
VANGUARD INTERMEDIATE
CVS HEALTH Corp reported holding 60,000 shares of VCIT (VANGUARD INTERMEDIATE) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 1.09% of its reported portfolio and ranking #21 among its reported holdings. CVS HEALTH Corp has disclosed VCIT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CVS HEALTH Corp's VCIT position evolved
CVS HEALTH Corp first disclosed a stake in VCIT in Q1 2026 at 60,000 shares (US$5.0M). Across 3 filings, CVS HEALTH Corp held the position steady without any share-count change. The most recent filing (Q3 2026) shows 60,000 shares valued at US$4.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 60.00K | $4.96M | New |
| Q2 2026 | 60.00K | $4.96M | Hold |
| Q3 2026 | 60.00K | $4.70M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCIT and 13F data
VCIT (VANGUARD INTERMEDIATE) is a company whose sector is not yet classified in our data. 24 other funds we track also report a position in VCIT — the largest reported positions include Bank of America Corp (US$9.97B), Fisher Asset Management, LLC (US$7.80B), JPMorgan Chase & Co (US$4.55B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCIT
- Bank of America Corp 120.65M sh · $9.97B · Q2 2026
- Fisher Asset Management, LLC 99.63M sh · $7.80B · Q3 2026
- JPMorgan Chase & Co 58.11M sh · $4.55B · Q3 2026
- Creative Planning 28.92M sh · $2.26B · Q3 2026
- ROYAL BANK OF CANADA 13.97M sh · $1.15B · Q2 2026
- Baird Financial Group, Inc. 9.32M sh · $729.96M · Q3 2026
- NEPC LLC 7.42M sh · $613.19M · Q2 2026
- PRUDENTIAL PLC 6.54M sh · $512.00M · Q3 2026
- Symetra Investment Management Co 6.02M sh · $471.54M · Q3 2026
- Wealthfront Advisers LLC 5.64M sh · $441.67M · Q3 2026
- American Family Investments, Inc. 5.01M sh · $413.95M · Q2 2026
- Wilshire Advisors LLC 4.97M sh · $389.44M · Q3 2026
More on CVS HEALTH Corp
FAQ
How long has CVS HEALTH Corp held VCIT?
CVS HEALTH Corp has disclosed VCIT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is CVS HEALTH Corp's current position in VCIT?
As of Q3 2026, CVS HEALTH Corp holds 60.00K shares of VCIT (VANGUARD INTERMEDIATE), valued at $4.70M, representing 1.09% of its reported portfolio and ranking #21.
Has CVS HEALTH Corp been buying or selling VCIT?
In the latest 13F filing (Q3 2026), CVS HEALTH Corp held unchanged its position in VCIT.
Which other funds hold VCIT?
Other major institutional holders of VCIT include Bank of America Corp, Fisher Asset Management, LLC, JPMorgan Chase & Co, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.